- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
ESHRE: Paxil Linked to Abortions, Not Congenital Defects
PRAGUE ? The evidence that led the FDA to warn that Paxil (paroxetine) taken during the first weeks of pregnancy increases the risk of birth defects, including serious heart defects, was disputed by German researchers today.
PRAGUE, June 19 ? The evidence that led the FDA to warn that Paxil (paroxetine) taken during the first weeks of pregnancy increases the risk of birth defects, including serious heart defects, was disputed by German researchers today.
In a German study women who used Paxil were, however, more likely to undergo abortion than women who didn't use an antidepressant during pregnancy (P
Podcast: Arthritis, Anxiety, and Depression: Managing a Common Comorbidity
May 14th 2012Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.
FDA Approves Esketamine as Monotherapy for Adults With Treatment-Resistant Depression
January 21st 2025The approval of esketamine follows an FDA Priority Review and is based on data showing that esketamine alone demonstrated rapid and superior improvement in depressive symptoms compared with placebo.
